Skip to main content
. 2022 Aug 17;20(8):e07420. doi: 10.2903/j.efsa.2022.7420

Table B.1.

Summary of Safety Evaluation by JECFA of the substances in FGE.19 subgroup 3.3, applying the Procedure (based on intakes calculated by the MSDI approach) (JECFA, 2006, 2015)

FL‐no

JECFA‐no

CAS no

EU Register name Structural formula MSDI (a) (μg/capita per day)

Class (b)

Evaluation procedure path (c) (JECFA)

Outcome on the named compound (JECFA, 2006) Outcome on the named compound (JECFA, 2015) EFSA conclusion on the named compound (genotoxicity)

05.062

1474

4411‐89‐6

2‐Phenylcrotonaldehyde graphic file with name EFS2-20-e07420-g015.jpg

1.7

Class I

A3: Intake below threshold

(d) (e) Concern for aneugenicity cannot be ruled out at the reported use levels.

05.099

1472

21834–92‐4

5‐Methyl‐2‐phenylhex‐2‐enal graphic file with name EFS2-20-e07420-g007.jpg

15

Class II

A3: Intake below threshold

(d) (e) Concern for aneugenicity cannot be ruled out. Additional genotoxicity data required.

05.100

1473

26643–91‐4

4‐Methyl‐2‐phenylpent‐2‐enal graphic file with name EFS2-20-e07420-g008.jpg

0.34

Class II

A3: Intake below threshold

(d) (e) Concern for aneugenicity cannot be ruled out. Additional genotoxicity data required.

05.175

3491‐63‐2

2‐Phenylpent‐2‐enal graphic file with name EFS2-20-e07420-g004.jpg 0.011 No evaluation Not evaluated by JECFA Not evaluated by JECFA Concern for aneugenicity cannot be ruled out. Additional genotoxicity data required.

05.222

2069

26643–92‐5

2‐Phenyl‐4‐methyl‐2‐hexenal graphic file with name EFS2-20-e07420-g002.jpg 3.0 No evaluation Not evaluated by JECFA (e) Concern for aneugenicity cannot be ruled out. Additional genotoxicity data required.
(a)

EU MSDI: Amount added to food as flavour in (kg/year) × 10E9/(0.1 × population in Europe (= 375 × 10E6) × 0.6 × 365) = μg/capita per day, calculated by EFSA based on the most recent data submitted.

(b)

Thresholds of toxicological concern: Class I = 1,800 μg/person per day, Class II = 540 μg/person per day, Class III = 90 μg/person per day.

(c)

Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.

(d)

No safety concern based on intake calculated by the MSDI approach of the named compound.

(e)

The Procedure cannot be applied until concerns regarding genotoxicity of 2‐phenyl‐2‐butenal (JECFA No. 1474) are resolved and the evaluation should be reconsidered at a future meeting.